Irinotecan in Treating Patients With Colorectal Cancer

NCT00003843 · clinicaltrials.gov ↗

TERMINATED

Status

28

Enrollment

NETWORK

Sponsor class

Stopped Study terminated due to poor accrual

Conditions

Colorectal Cancer

Interventions

DRUG: irinotecan hydrochloride
GENETIC: mutation analysis
GENETIC: polymorphism analysis

Sponsor

California Cancer Consortium

Collaborators

[object Object]